Stroke recurrence and its prevention in patients with patent Foramen ovale

被引:36
|
作者
Harrer, JU
Wessels, T
Franke, A
Lucas, S
Berlit, R
Klötzsch, C
机构
[1] RWTH Aachen Univ Hosp, Dept Neurol, D-52074 Aachen, Germany
[2] RWTH Aachen Univ Hosp, Med Clin 1, Dept Cardiol, D-52074 Aachen, Germany
[3] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany
[4] Alfred Krupp Hosp, Dept Neurol, Essen, Germany
关键词
D O I
10.1017/S0317167100004674
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is unclear whether medical or invasive (surgical or catheter interventional) treatment is preferable to prevent recurrence of cerebral ischemia in patients with patent foramen ovale (PFO) as the Suspected cause of stroke and what the role of concomitant risk factors is in stroke recurrence. Methods: Over it period of ten years, 124 patients (mean age 5 1 15 years) with cryptogenic cerebral ischemia and PFO were included into the Study and prospectively followed over a mean of 52 32 months. Of these, 83 were treated medically, 34 underwent transcatheter closure, and seven had surgical closure of the foramen. Of the medically treated patients, 11 stopped medication during follow-up. Recurrent ischemic events and risk factors for recurrence were analyzed. Results: Annual stroke recurrence rates were generally low and comparable in catheter and medically treated patients, and in patients who had stopped medication (2.9%/2.1%/2.2%/ycar). Patients suffering from recurrence after transcatheter closure (n=2) both had residual shunts. No stroke recurrence was observed in the few surgically treated patients. An atrial septal aneurysm was not a predictor of recurrent or multiple strokes (p > 0.05, OR=0.31, and OR=0.74). Large shunts and a history of previous ischemic events were considerably more frequent in patients with recurrent strokes (p < 0.05, OR=5.0, and OR=4.4). Pulmonary embolism and case fatality rates were significantly higher in patients with stroke recurrence (p < 0.001, and p < 0.01). Conclusions: The absolute risk of recurrent cerebrovascular events in patients with PFO receiving medical or catheter interventional therapy is low. The small group of untreated patients had a comparably low rate of stroke recurrences. Previous ischemic events and shunt size were risk factors in this observational study. Given conflicting findings across multiple Studies, enrollment into a randomized controlled trial Would be the optimal choice.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [1] Stroke recurrence in patients with patent foramen ovale
    La Gioia, S.
    Ghidinelli, C.
    Roveri, L.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2009, 256 : S173 - S173
  • [2] Prevention of stroke in patients with patent foramen ovale
    Mattle, H. P.
    Meier, B.
    Nedeltchev, K.
    INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (02) : 92 - 102
  • [3] Stroke Prevention in Patients with Patent Foramen Ovale
    Thaler, Alison
    Kvernland, Alexandra
    Kelly, Sean
    Song, Christopher
    Aparicio, Hugo J.
    Mac Grory, Brian
    Yaghi, Shadi
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (12)
  • [4] Stroke Prevention in Patients with Patent Foramen Ovale
    Alison Thaler
    Alexandra Kvernland
    Sean Kelly
    Christopher Song
    Hugo J. Aparicio
    Brian Mac Grory
    Shadi Yaghi
    Current Cardiology Reports, 2021, 23
  • [5] Optimal stroke prevention in patients with patent foramen ovale
    Meier, Bernhard
    LANCET NEUROLOGY, 2018, 17 (12): : 1027 - 1028
  • [6] Secondary stroke prevention in patients with patent foramen ovale
    Rhoades, Ruben
    Tzeng, Diana
    Ruggiero, Nicholas
    CURRENT OPINION IN HEMATOLOGY, 2021, 28 (05) : 292 - 300
  • [7] Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale
    Wessler, Benjamin S.
    Kent, David M.
    NEUROLOGIC CLINICS, 2015, 33 (02) : 491 - +
  • [8] Stroke recurrence in patients with patent foramen ovale: The Lausanne Study
    Bogousslavsky, J
    Garazi, S
    Jeanrenaud, X
    Aebischer, N
    VanMelle, G
    NEUROLOGY, 1996, 46 (05) : 1301 - 1305
  • [9] Patent foramen ovale closure for stroke prevention
    Czarniak, Bartosz
    Kaczmarek, Krzysztof
    Jakubowski, Piotr
    Drozdz, Jaroslaw
    POLISH HEART JOURNAL-KARDIOLOGIA POLSKA, 2025, 83 (02): : 191 - 193
  • [10] Types of Stroke Recurrence in Cryptogenic Stroke with Patent Foramen Ovale
    Nagakane, Y.
    Tanaka, E.
    Ashida, S.
    Kojima, Y.
    Ogura, S.
    Maezono, K.
    CEREBROVASCULAR DISEASES, 2016, 42 : 122 - 122